15-Lipoxygenase-2 gene regulation by its product 15-(S)- hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor γ

Oncogene

Volumn 25, Issue 44, 2006, Pages 6015-6025

  Subbarayan, V ^a   Krieg, P ^b   Hsi, L C ^a   Kim, J ^a   Yang, P ^a   Sabichi, A L ^a   Llansa, N ^a   Mendoza, G ^a   Logothetis, C J ^a   Newman, R A ^a   Lippman, S M ^a   Menter, D G ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

15 lipoxygenase 2; Gene expression; Peroxisome proliferator activated receptor ; Prostate cancer

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; 15 LIPOXYGENASE 2; OLIGONUCLEOTIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; HUMAN; HUMAN CELL; MALE; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; TRANSCRIPTION INITIATION;

5' UNTRANSLATED REGIONS; ARACHIDONATE 15-LIPOXYGENASE; CELL LINE; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 17; CLONING, MOLECULAR; DOWN-REGULATION; ENHANCER ELEMENTS (GENETICS); FEEDBACK, BIOCHEMICAL; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; MALE; PPAR GAMMA; PROMOTER REGIONS (GENETICS); PROSTATE; PROSTATIC NEOPLASMS; RECEPTOR CROSS-TALK; UP-REGULATION;

EID: 33749188417     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209617     Document Type: Article

References (39)

1. Berhane K, Boggaram V. (2001). Gene 268: 141-151.
2. Bhatia B, Maldonado CJ, Tang S, Chandra D, Klein RD, Chopra D et al. (2003). J Biol Chem 278: 25091-25100.
3. Bhatia B, Tang S, Yang P, Doll A, Aumueller G, Newman RA et al. (2005). Oncogene 24: 2583-3595.
4. Blanquart C, Barbier O, Fruchart JC, Staels B, Glineur C. (2003). J Steroid Biochem Mol Biol 85: 267-273.
5. Brash AR, Boeglin WE, Chang MS. (1997). Proc Natl Acad Sci USA 94: 6148-6152.
6. Butler R, Mitchell SH, Tindall DJ, Young CY. (2000). Cell Growth Differ 11: 49-61.
7. Cato AC, Nestl A, Mink S. (2002). Sci STKE 2002: RE9.
8. Elbrecht A, Chen Y, Cullinan CA, Hayes N, Leibowitz M, Moller DE et al. (1996). Biochem Biophys Res Commun 224: 431-437.
9. Flores AM, Li L, McHugh NG, Aneskievich BJ. (2005). Chem Biol Interact 151: 121-132.
10. Giguere V, Tini M, Flock G, Ong E, Evans RM, Otulakowski G. (1994). Genes Dev 8: 538-553.
11. Gurnell M, Wentworth JM, Agostini M, Adams M, Collingwood TN, Provenzano C et al. (2000). J Biol Chem 275: 5754-5759.
12. Hsi LC, Wilson LC, Eling TE. (2002). J Biol Chem 277: 40549-40556.
13. Huang JT, Welch JS, Ricote M, Binder CJ, Willson TM, Kelly C et al. (1999). Nature 400: 378-382.
14. Jack GS, Brash AR, Olson SJ, Manning S, Coffey CS, Smith Jr JA et al. (2000). Hum Pathol 31: 1146-1154.
15. Kang LT, Vanderhoek JY. (1998). J Lipid Res 39: 1476-1482.
16. Kilty I, Logan A, Vickers PJ. (1999). Eur J Biochem 266: 83-93.
17. Kim J, Yang P, Sabichi A, Llansa N, Mendoza G, Subbarayan V et al. (2005). Cancer Res 65: 6189-6198.
18. Koeffler H. (2003). Clin Cancer Res 9: 1-9.
19. Krieg P, Marks F, Furstenberger G. (2001). Genomics 73: 323-330.
20. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K et al. (1995). Cell 83: 835-839.
21. Moretti RM, Marelli MM, Motta M, Limonta P. (2002). Oncol Rep 9: 1139-1143.
22. Moretti RM, Marelli MM, Motta M, Polizzi D, Monestiroli S, Pratesi G et al. (2001). Prostate 46: 327-335.
23. Moretti RM, Montagnani Marelli M, Sala A, Motta M, Limonta P. (2004). Int J Cancer 112: 87-93.
24. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM. (1998). Cell 93: 229-240.
25. Salas TR, Reddy SA, Clifford JL, Davis RJ, Kikuchi A, Lippman SM et al. (2003). J Biol Chem 278: 41338-41346.
26. Schreiber E, Matthias P, Muller MM, Schaffner W. (1989). Nucleic Acids Res 17: 6419.
27. Shankaranarayanan P, Nigam S. (2003). J Immunol 170: 887-894.
28. Shappell SB, Boeglin WE, Olson SJ, Kasper S, Brash AR. (1999). Am J Pathol 155: 235-245.
29. Shappell SB, Gupta RA, Manning S, Whitehead R, Boeglin WE, Schneider C et al. (2001). Cancer Res 61: 497-503.
30. Sharma GD, Ottino P, Bazan NG, Bazan HE. (2005). J Biol Chem 280: 7917-7924.
31. Steinhilber D, Brungs M, Werz O, Wiesenberg I, Danielsson C, Kahlen JP et al. (1995). J Biol Chem 270: 7037-7040.
32. Subbarayan V, Sabichi AL, Kim J, Llansa N, Logothetis CJ, Lippman SM et al. (2004). Cancer Epidemiol Biomarkers Prev 13: 1710-1716.
33. Subbarayan V, Sabichi AL, Llansa N, Lippman SM, Menter DG. (2001). Cancer Res 61: 2720-2726.
34. Subbarayan V, Xu XC, Kim J, Yang P, Hoque A, Sabichi AL et al. (2005). Neoplasia 7: 280-293.
35. Tang S, Bhatia B, Maldonado CJ, Yang P, Newman RA, Liu J et al. (2002). J Biol Chem 277: 16189-16201.
36. Tang S, Bhatia B, Zhou J, Maldonado CJ, Chandra D, Kim E et al. (2004). Oncogene 23: 6942-6953.
37. Warnmark A, Treuter E, Wright AP, Gustafsson JA. (2003). Mol Endocrinol 17: 1901-1909.
38. Wigren J, Surapureddi S, Olsson AG, Glass CK, Hammarstrom S, Soderstrom M. (2003). J Endocrinol 177: 207-214.
39. Xu XC, Shappell SB, Liang Z, Song S, Menter D, Subbarayan V et al. (2003). Neoplasia 5: 121-127.